Form 8-K Lipocine Inc. For: Oct 07
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Health Canada approves Tlando oral testosterone therapy from Lipocine
October 7, 2026 6:13 AM EDTHealth Canada has approved TLANDO (testosterone undecanoate) capsules for testosterone replacement therapy (TRT) in adult males with hypogonadism, according to a statement from Lipocine Inc. (NASDAQ: LPCN).
The approval was obtained through Verity Pharmaceuticals Inc., Lipocine's licensing partner, which holds exclusive commercial... More



